Brosils 20 mg pastile
| Name | Brosils 20 mg pastile |
|---|---|
| Former Name | Ambroksolklorid Galenika 20 mg pastile |
| Marketing Authorisation Number | HR-H-266077631 |
| Active Substance | ambroksolklorid |
| Composition | svaka pastila sadrži 20 mg ambroksolklorida |
| Pharmaceutical Form | Pastila |
| Manufacturer | Netpharmalab Consulting Services S.L., Alcobendas, Madrid, Španjolska Infarmade S.L., c/Torre de los Herberos, 35. PI, Carretera de la Isla, Dos Hermanas, Španjolska |
| Marketing Authorisation Holder | Galenika International Kft., Baross utca 165/3, Budaörs, Mađarska |
| Marketing Authorisation Date | 28.06.2023 |
| MA Period of Validity | 28.06.2028 |
| Classification Number | UP/I-530-09/23-01/13 |
| Registration Number | 381-12-01/286-23-10 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R02AD |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
